G1 Therapeutics, Inc.
GTHX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $32 | $95 | $221 | $207 |
| Short-Term Investments | $50 | $50 | $0 | $0 |
| Receivables | $13 | $11 | $6 | $0 |
| Inventory | $12 | $16 | $3 | $0 |
| Other Curr. Assets | $8 | $7 | $13 | $9 |
| Total Curr. Assets | $115 | $180 | $244 | $216 |
| Property Plant & Equip (Net) | $6 | $8 | $9 | $11 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $1 | $1 |
| Total NC Assets | $7 | $8 | $11 | $12 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $122 | $188 | $254 | $229 |
| Liabilities | – | – | – | – |
| Payables | $4 | $7 | $3 | $4 |
| Short-Term Debt | $0 | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $0 | $0 | $0 |
| Other Curr. Liab. | $25 | $27 | $24 | $20 |
| Total Curr. Liab. | $30 | $36 | $28 | $23 |
| LT Debt | $56 | $83 | $82 | $28 |
| Deferred Rev, NC | $1 | $1 | $1 | $0 |
| Deferred Tax Liab, NC | $4 | -$77 | -$75 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $56 | $84 | $83 | $28 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $7 | $8 | $8 |
| Total Liabilities | $86 | $119 | $111 | $51 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$780 | -$732 | -$584 | -$436 |
| AOCI | -$0 | -$0 | -$0 | $0 |
| Other Equity | $815 | $801 | $728 | $613 |
| Total Equity | $35 | $69 | -$584 | -$436 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $122 | $188 | -$474 | -$385 |
| Net Debt | $24 | -$11 | -$138 | -$180 |